Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ef01e33058cf740cf2197991be97af1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
filingDate |
2000-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2002-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1664ba16565d6a706a6b22bbf84b0738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c908c6c1acbb5601273085c81b5ced http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05413d024572ddb2d1bffa29bf5cd7b |
publicationDate |
2002-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6342241-B1 |
titleOfInvention |
Medical composition of hydroxy acid-based oligomer |
abstract |
A medical composition is here disclosed which comprises a hydroxy acid-based oligomer (A) and a drug (B), wherein the hydroxy acid-based oligomer (A) is an oligomer in which the carboxylic acid-terminals are at least partially esterified, and the oligomer (A) has a function of becoming pH 5 to 8 when administered into an organism, and the oligomer (A) shows fluidity at 25° C. This composition sustainedly releases the drug (B) to deliver it into an organism by a syringe or the like, and scarcely gives rise to irritation, inflammation or the like. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010030106-A1 |
priorityDate |
1999-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |